Comprehensive Hereditary Cancer Panel 150 Genes Test
Understanding Hereditary Cancer Risk Assessment
The Comprehensive Hereditary Cancer Panel 150 Genes Test represents a breakthrough in preventive healthcare, offering unprecedented insight into your genetic predisposition to cancer. This advanced screening analyzes 150 carefully selected genes associated with hereditary cancer syndromes, providing a comprehensive overview of your inherited cancer risks. By identifying specific genetic mutations, this test empowers individuals and healthcare providers to implement targeted prevention strategies and personalized screening protocols.
What This Test Measures and Detects
Our comprehensive panel utilizes state-of-the-art Next Generation Sequencing technology to examine 150 genes linked to hereditary cancer syndromes. The test specifically identifies:
- BRCA1 and BRCA2 mutations associated with breast and ovarian cancer
- Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2) for colorectal and endometrial cancer
- TP53 mutations linked to Li-Fraumeni syndrome
- APC gene variants for familial adenomatous polyposis
- Multiple other cancer predisposition genes across various organ systems
Technical Excellence in Molecular Diagnostics
Conducted in our CLIA-certified molecular diagnostics laboratory, this test achieves exceptional accuracy through comprehensive sequencing coverage and rigorous quality control measures. Our methodology ensures detection of various mutation types including single nucleotide variants, small insertions/deletions, and copy number variations.
Who Should Consider This Genetic Cancer Screening
This comprehensive hereditary cancer panel is particularly recommended for individuals with:
- Personal history of cancer diagnosed at an early age
- Multiple primary cancers in the same individual
- Family history of cancer across multiple generations
- Known genetic mutations in the family
- Rare cancers or specific cancer patterns in relatives
- Ashkenazi Jewish ancestry with increased BRCA mutation risk
- Concerns about inherited cancer risks despite negative family history
Clinical Indications and Risk Factors
Consider this test if you experience unexplained symptoms or have risk factors including unusual lumps, persistent pain, unexplained weight loss, or changes in bowel/bladder habits. Early genetic assessment can significantly impact cancer prevention and management strategies.
Benefits of Comprehensive Cancer Genetic Testing
Undergoing the Comprehensive Hereditary Cancer Panel offers numerous advantages:
- Early Risk Identification: Detect genetic predispositions before cancer develops
- Personalized Screening: Tailor surveillance protocols based on specific genetic risks
- Family Planning Insights: Understand inheritance patterns for future generations
- Preventive Interventions: Implement lifestyle changes and preventive measures
- Treatment Guidance: Inform therapeutic decisions if cancer develops
- Peace of Mind: Reduce anxiety through knowledge and proactive management
Understanding Your Test Results
Your comprehensive genetic report will be thoroughly explained by our genetic counselors and healthcare providers. Results typically fall into three categories:
Positive Result
A positive result indicates the presence of a pathogenic mutation associated with increased cancer risk. This information enables:
- Enhanced surveillance and screening protocols
- Preventive surgical options when appropriate
- Family member testing recommendations
- Personalized risk reduction strategies
Negative Result
A negative result suggests no known pathogenic mutations were detected in the tested genes. However, this doesn’t eliminate all cancer risks, as:
- Other genetic factors may contribute to cancer risk
- Environmental and lifestyle factors remain important
- Standard cancer screening recommendations still apply
Variant of Uncertain Significance (VUS)
Some genetic changes have unknown clinical significance. Our team provides guidance on:
- Interpreting VUS results in clinical context
- Ongoing research and database updates
- Appropriate follow-up and management
Test Information and Pricing
| Test Component | Details |
|---|---|
| Test Name | Comprehensive Hereditary Cancer Panel 150 Genes Test |
| Regular Price | $812 USD |
| Discount Price | $450 USD |
| Turnaround Time | 4 weeks |
| Sample Type | Blood |
| Test Method | Next Generation Sequencing |
| Genes Analyzed | 150 cancer-associated genes |
Pre-Test Requirements
Before testing, please ensure you have completed the Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27). This comprehensive form helps our genetic specialists understand your personal and family medical history, ensuring optimal test interpretation and clinical relevance.
Nationwide Accessibility and Convenience
We proudly serve patients across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures easy access to this vital genetic testing service.
Take Control of Your Cancer Risk Assessment Today
Don’t wait to gain crucial insights into your hereditary cancer risks. Our comprehensive 150-gene panel provides the detailed genetic information needed to make informed healthcare decisions. With our special discounted price of $450 USD, comprehensive cancer genetic testing has never been more accessible.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or speak with our genetic counseling team. Take the first step toward personalized cancer prevention and early detection strategies.
Our experienced team of genetic counselors, oncologists, and molecular diagnostics specialists are ready to guide you through the testing process and help interpret your results within the context of your personal and family medical history.
